PDB Short entry for 2OJU
HEADER    ISOMERASE/IMMUNOSUPPRESSANT             14-JAN-07   2OJU              
TITLE     X-RAY STRUCTURE OF COMPLEX OF HUMAN CYCLOPHILIN J WITH CYCLOSPORIN A  
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE-LIKE 3;                
COMPND   3 CHAIN: A, B;                                                         
COMPND   4 SYNONYM: PPIASE, ROTAMASE, CYCLOPHILIN-LIKE PROTEIN PPIL3,           
COMPND   5 CYCLOPHILIN J, CYPJ;                                                 
COMPND   6 EC: 5.2.1.8;                                                         
COMPND   7 ENGINEERED: YES;                                                     
COMPND   8 MOL_ID: 2;                                                           
COMPND   9 MOLECULE: CYCLOSPORIN A;                                             
COMPND  10 CHAIN: C, D;                                                         
COMPND  11 SYNONYM: CICLOSPORIN, CICLOSPORINE;                                  
COMPND  12 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 TISSUE: FETAL BRAIN;                                                 
SOURCE   6 GENE: PPIL3B;                                                        
SOURCE   7 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   8 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   9 EXPRESSION_SYSTEM_STRAIN: ER2566;                                    
SOURCE  10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE  11 EXPRESSION_SYSTEM_PLASMID: PTXB1;                                    
SOURCE  12 MOL_ID: 2;                                                           
SOURCE  13 SYNTHETIC: YES;                                                      
SOURCE  14 ORGANISM_SCIENTIFIC: TOLYPOCLADIUM INFLATUM;                         
SOURCE  15 ORGANISM_TAXID: 29910                                                
KEYWDS    ISOMERASE-IMMUNOSUPPRESSANT COMPLEX, CYCLOPHILIN-CYCLOSPORIN COMPLEX, 
KEYWDS   2 CYCLOSPORIN A, IMMUNOSUPPRESSANT, CYCLOPHILIN                        
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    Z.XIA,L.HUANG                                                         
REVDAT   6   15-NOV-23 2OJU    1       LINK                                     
REVDAT   5   25-OCT-23 2OJU    1       SEQADV LINK                              
REVDAT   4   27-JUL-11 2OJU    1       REMARK                                   
REVDAT   3   13-JUL-11 2OJU    1       VERSN                                    
REVDAT   2   24-FEB-09 2OJU    1       VERSN                                    
REVDAT   1   22-JAN-08 2OJU    0                                                
JRNL        AUTH   J.CHEN,S.CHEN,L.HUANG,X.ZHAO,J.TAN,C.HUANG,H.SAIYIN,M.ZHANG, 
JRNL        AUTH 2 X.ZENG,J.XI,B.WAN,Y.ZHAO,Z.XIA,H.JIANG,Q.YI,J.O.LIU,L.YU     
JRNL        TITL   TARGETING CYCLOPHILIN J, A NOVEL PEPTIDYL-PROLYL ISOMERASE,  
JRNL        TITL 2 CAN INDUCE CELLULAR G1/S ARREST AND REPRESS THE GROWTH OF    
JRNL        TITL 3 HEPATOCELLULAR CARCINOMA                                     
JRNL        REF    TO BE PUBLISHED                                              
JRNL        REFN                                                                
REMARK   2                                                                      
REMARK   2 RESOLUTION.    2.40 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS 1.1                                              
REMARK   3   AUTHORS     : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-              
REMARK   3               : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,              
REMARK   3               : READ,RICE,SIMONSON,WARREN                            
REMARK   3                                                                      
REMARK   3  REFINEMENT TARGET : NULL                                            
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 30.00                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : 220039.630                     
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : 0.0000                         
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : 93.7                           
REMARK   3   NUMBER OF REFLECTIONS             : 18460                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE            (WORKING SET) : 0.193                           
REMARK   3   FREE R VALUE                     : 0.237                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 9.700                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 1793                            
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : 0.006                           
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : 10                           
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 2.40                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.49                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 72.60                        
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : 1264                         
REMARK   3   BIN R VALUE           (WORKING SET) : 0.3590                       
REMARK   3   BIN FREE R VALUE                    : 0.4290                       
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : 9.60                         
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : 135                          
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : 0.037                        
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 2762                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 0                                       
REMARK   3   SOLVENT ATOMS            : 32                                      
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 42.50                          
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 51.30                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : -2.47000                                             
REMARK   3    B22 (A**2) : -2.47000                                             
REMARK   3    B33 (A**2) : 4.95000                                              
REMARK   3    B12 (A**2) : 1.34000                                              
REMARK   3    B13 (A**2) : 0.00000                                              
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED COORDINATE ERROR.                                         
REMARK   3   ESD FROM LUZZATI PLOT        (A) : 0.31                            
REMARK   3   ESD FROM SIGMAA              (A) : 0.43                            
REMARK   3   LOW RESOLUTION CUTOFF        (A) : 5.00                            
REMARK   3                                                                      
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.                         
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : 0.39                            
REMARK   3   ESD FROM C-V SIGMAA          (A) : 0.52                            
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   
REMARK   3   BOND LENGTHS                 (A) : 0.007                           
REMARK   3   BOND ANGLES            (DEGREES) : 1.300                           
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : 24.90                           
REMARK   3   IMPROPER ANGLES        (DEGREES) : 0.770                           
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL MODEL : RESTRAINED                                
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                
REMARK   3   MAIN-CHAIN BOND              (A**2) : 1.400 ; 1.500                
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : 2.330 ; 2.000                
REMARK   3   SIDE-CHAIN BOND              (A**2) : 2.100 ; 2.000                
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : 3.230 ; 2.500                
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED : FLAT MODEL                                           
REMARK   3   KSOL        : 0.28                                                 
REMARK   3   BSOL        : 33.27                                                
REMARK   3                                                                      
REMARK   3  NCS MODEL : NULL                                                    
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT          
REMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL                 
REMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  PARAMETER FILE  1  : WATER_REP.PARAM                                
REMARK   3  PARAMETER FILE  2  : ION.PARAM                                      
REMARK   3  PARAMETER FILE  3  : NULL                                           
REMARK   3  TOPOLOGY FILE  1   : WATER.TOP                                      
REMARK   3  TOPOLOGY FILE  2   : ION.TOP                                        
REMARK   3  TOPOLOGY FILE  3   : NULL                                           
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 2OJU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 23-JAN-07.                  
REMARK 100 THE DEPOSITION ID IS D_1000041225.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 26-FEB-05                          
REMARK 200  TEMPERATURE           (KELVIN) : 293.0                              
REMARK 200  PH                             : 7.4                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : BSRF                               
REMARK 200  BEAMLINE                       : 3W1A                               
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.9826                             
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : NULL                               
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : HKL-2000                           
REMARK 200  DATA SCALING SOFTWARE          : HKL-2000                           
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 19272                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.400                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 50.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 0.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 97.6                               
REMARK 200  DATA REDUNDANCY                : NULL                               
REMARK 200  R MERGE                    (I) : 0.07600                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : NULL                               
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.49                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 83.4                               
REMARK 200  DATA REDUNDANCY IN SHELL       : NULL                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.40600                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : NULL                               
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: AMORE                                                 
REMARK 200 STARTING MODEL: 2OK3                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 59.63                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.04                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1MOL/L TRIS-HCL(PH=7.4), 6%(V/V)       
REMARK 280  DMSO, 18%(W/V) PEG8000, VAPOR DIFFUSION, HANGING DROP,              
REMARK 280  TEMPERATURE 293.0K, PH 7.4                                          
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1                         
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -Y,X-Y,Z+1/3                                            
REMARK 290       3555   -X+Y,-X,Z+2/3                                           
REMARK 290       4555   Y,X,-Z                                                  
REMARK 290       5555   X-Y,-Y,-Z+2/3                                           
REMARK 290       6555   -X,-X+Y,-Z+1/3                                          
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -0.500000 -0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.866025 -0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       66.98100            
REMARK 290   SMTRY1   3 -0.500000  0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   3 -0.866025 -0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000      133.96200            
REMARK 290   SMTRY1   4 -0.500000  0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   4  0.866025  0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   5  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   5  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   5  0.000000  0.000000 -1.000000      133.96200            
REMARK 290   SMTRY1   6 -0.500000 -0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   6 -0.866025  0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   6  0.000000  0.000000 -1.000000       66.98100            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1, 2                                                    
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 1030 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 8710 ANGSTROM**2                        
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.3 KCAL/MOL                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 2                                                       
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 1040 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 8610 ANGSTROM**2                        
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.6 KCAL/MOL                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 400                                                                      
REMARK 400 COMPOUND                                                             
REMARK 400 CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.                               
REMARK 400   HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES)        
REMARK 400                                                                      
REMARK 400 THE CYCLOSPORIN A IS CYCLIC PEPTIDE, A MEMBER OF IMMUNOSUPPRESSANT   
REMARK 400 CLASS.                                                               
REMARK 400                                                                      
REMARK 400  GROUP: 1                                                            
REMARK 400   NAME: CYCLOSPORIN A                                                
REMARK 400   CHAIN: C, D                                                        
REMARK 400   COMPONENT_1: PEPTIDE LIKE POLYMER                                  
REMARK 400   DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION    
REMARK 400                IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI.     
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     SER A     1                                                      
REMARK 465     ARG A     2                                                      
REMARK 465     ALA A   166                                                      
REMARK 465     GLN A   167                                                      
REMARK 465     GLN B   167                                                      
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASP A  14      -15.59    -49.93                                   
REMARK 500    PHE A  55      -82.44   -108.18                                   
REMARK 500    PHE B  23       73.17    -69.94                                   
REMARK 500    THR B  27       76.80   -115.90                                   
REMARK 500    PHE B  55      -85.20   -105.47                                   
REMARK 500    LYS B 139       39.71    -80.86                                   
REMARK 500    ASN B 143     -130.97    -61.90                                   
REMARK 500    GLU B 144      -30.19   -158.08                                   
REMARK 500    ABA D   6       76.79   -119.13                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 650                                                                      
REMARK 650 HELIX                                                                
REMARK 650 DETERMINATION METHOD: AUTHOR DETERMINED                              
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF CYCLOSPORIN A          
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF CYCLOSPORIN A          
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1BCK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN  
REMARK 900 C                                                                    
REMARK 900 RELATED ID: 1C5F   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI  
REMARK 900 COMPLEXED WITH CYCLOSPORIN A                                         
REMARK 900 RELATED ID: 1CSA   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF E.COLI CYCLOPHILIN (F112W) COMPLEXED WITH      
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 1CWA   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN  
REMARK 900 A                                                                    
REMARK 900 RELATED ID: 1CWB   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 5                                          
REMARK 900 RELATED ID: 1CWC   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 8                                          
REMARK 900 RELATED ID: 1CWF   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN  
REMARK 900 D                                                                    
REMARK 900 RELATED ID: 1CWH   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN  
REMARK 900 A MODIFIED AT POSITION 7                                             
REMARK 900 RELATED ID: 1CWI   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN D AT POSITION 7                                          
REMARK 900 RELATED ID: 1CWJ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7.                                  
REMARK 900 RELATED ID: 1CWK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7.                                  
REMARK 900 RELATED ID: 1CWL   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 8                                          
REMARK 900 RELATED ID: 1CWM   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 8                                          
REMARK 900 RELATED ID: 1CWO   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH NODIFIED     
REMARK 900 CYCLOSPORIN C AT POSITIONS 1, AND 9                                  
REMARK 900 RELATED ID: 1CYA   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A 
REMARK 900 RELATED ID: 1CYB   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A 
REMARK 900 RELATED ID: 1CYN   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN B COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 1                                          
REMARK 900 RELATED ID: 1M63   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN COMPLEX     
REMARK 900 RELATED ID: 1MF8   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH HUMAN          
REMARK 900 CYCLOPHILIN AND CYCLOSPORIN A                                        
REMARK 900 RELATED ID: 1MIK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 6                                          
REMARK 900 RELATED ID: 1QNG   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN COMPLEXED     
REMARK 900 WITH CYCLOSPORIN A                                                   
REMARK 900 RELATED ID: 1QNH   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE       
REMARK 900 MUTANT) COMPLEXED WITH CYCLOSPORIN A                                 
REMARK 900 RELATED ID: 1XQ7   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYCLOPHILIN COMPLEXED WITH    
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 2ESL   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN C COMPLEXED WITH CYCLOSPORIN  
REMARK 900 A                                                                    
REMARK 900 RELATED ID: 2POY   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM IOWA II CYCLOPHILIN A    
REMARK 900 COMPLEXED WITH CYCLOSPORIN A                                         
REMARK 900 RELATED ID: 2RMA   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN  
REMARK 900 A                                                                    
REMARK 900 RELATED ID: 2RMB   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 5                                          
REMARK 900 RELATED ID: 2RMC   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH             
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 2WFJ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF HUMAN CYCLOPHILIN G        
REMARK 900 COMPLEXED WITH CYCLOSPORIN A                                         
REMARK 900 RELATED ID: 2X2C   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN ACETYL-CYPA COMPLEXED WITH CYCLOSPORINE A 
REMARK 900 RELATED ID: 2X7K   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF PPIL1 COMPLEXED WITH CYCLOSPORINE A             
REMARK 900 RELATED ID: 2Z6W   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D IN COMPLEX WITH             
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 3BO7   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CYCLOSPHILIN A FROM TOXOPLASMA GONDII           
REMARK 900 COMPLEXED WIT CYCLOSPORIN A                                          
REMARK 900 RELATED ID: 3CYS   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF THE HUMAN CYCLOSPORIN A COMPLEXED WITH         
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 3EOV   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI COMPLEXED  
REMARK 900 WITH CYCLOSPORIN A                                                   
REMARK 999                                                                      
REMARK 999 SEQUENCE                                                             
REMARK 999 THE N-TERMINAL 6 RESIDUES 'SRVDGG' IN CHAINS A AND B IS              
REMARK 999 AN ENGINEERED EXPRESSION TAG                                         
DBREF  2OJU A    7   167  UNP    Q9H2H8   PPIL3_HUMAN      1    161             
DBREF  2OJU B    7   167  UNP    Q9H2H8   PPIL3_HUMAN      1    161             
DBREF  2OJU C    1    11  NOR    NOR00033 NOR00033         1     11             
DBREF  2OJU D    1    11  NOR    NOR00033 NOR00033         1     11             
SEQADV 2OJU SER A    1  UNP  Q9H2H8              EXPRESSION TAG                 
SEQADV 2OJU ARG A    2  UNP  Q9H2H8              EXPRESSION TAG                 
SEQADV 2OJU VAL A    3  UNP  Q9H2H8              EXPRESSION TAG                 
SEQADV 2OJU ASP A    4  UNP  Q9H2H8              EXPRESSION TAG                 
SEQADV 2OJU GLY A    5  UNP  Q9H2H8              EXPRESSION TAG                 
SEQADV 2OJU GLY A    6  UNP  Q9H2H8              EXPRESSION TAG                 
SEQADV 2OJU SER B    1  UNP  Q9H2H8              EXPRESSION TAG                 
SEQADV 2OJU ARG B    2  UNP  Q9H2H8              EXPRESSION TAG                 
SEQADV 2OJU VAL B    3  UNP  Q9H2H8              EXPRESSION TAG                 
SEQADV 2OJU ASP B    4  UNP  Q9H2H8              EXPRESSION TAG                 
SEQADV 2OJU GLY B    5  UNP  Q9H2H8              EXPRESSION TAG                 
SEQADV 2OJU GLY B    6  UNP  Q9H2H8              EXPRESSION TAG                 
SEQRES   1 A  167  SER ARG VAL ASP GLY GLY MET SER VAL THR LEU HIS THR          
SEQRES   2 A  167  ASP VAL GLY ASP ILE LYS ILE GLU VAL PHE CYS GLU ARG          
SEQRES   3 A  167  THR PRO LYS THR CYS GLU ASN PHE LEU ALA LEU CYS ALA          
SEQRES   4 A  167  SER ASN TYR TYR ASN GLY CYS ILE PHE HIS ARG ASN ILE          
SEQRES   5 A  167  LYS GLY PHE MET VAL GLN THR GLY ASP PRO THR GLY THR          
SEQRES   6 A  167  GLY ARG GLY GLY ASN SER ILE TRP GLY LYS LYS PHE GLU          
SEQRES   7 A  167  ASP GLU TYR SER GLU TYR LEU LYS HIS ASN VAL ARG GLY          
SEQRES   8 A  167  VAL VAL SER MET ALA ASN ASN GLY PRO ASN THR ASN GLY          
SEQRES   9 A  167  SER GLN PHE PHE ILE THR TYR GLY LYS GLN PRO HIS LEU          
SEQRES  10 A  167  ASP MET LYS TYR THR VAL PHE GLY LYS VAL ILE ASP GLY          
SEQRES  11 A  167  LEU GLU THR LEU ASP GLU LEU GLU LYS LEU PRO VAL ASN          
SEQRES  12 A  167  GLU LYS THR TYR ARG PRO LEU ASN ASP VAL HIS ILE LYS          
SEQRES  13 A  167  ASP ILE THR ILE HIS ALA ASN PRO PHE ALA GLN                  
SEQRES   1 B  167  SER ARG VAL ASP GLY GLY MET SER VAL THR LEU HIS THR          
SEQRES   2 B  167  ASP VAL GLY ASP ILE LYS ILE GLU VAL PHE CYS GLU ARG          
SEQRES   3 B  167  THR PRO LYS THR CYS GLU ASN PHE LEU ALA LEU CYS ALA          
SEQRES   4 B  167  SER ASN TYR TYR ASN GLY CYS ILE PHE HIS ARG ASN ILE          
SEQRES   5 B  167  LYS GLY PHE MET VAL GLN THR GLY ASP PRO THR GLY THR          
SEQRES   6 B  167  GLY ARG GLY GLY ASN SER ILE TRP GLY LYS LYS PHE GLU          
SEQRES   7 B  167  ASP GLU TYR SER GLU TYR LEU LYS HIS ASN VAL ARG GLY          
SEQRES   8 B  167  VAL VAL SER MET ALA ASN ASN GLY PRO ASN THR ASN GLY          
SEQRES   9 B  167  SER GLN PHE PHE ILE THR TYR GLY LYS GLN PRO HIS LEU          
SEQRES  10 B  167  ASP MET LYS TYR THR VAL PHE GLY LYS VAL ILE ASP GLY          
SEQRES  11 B  167  LEU GLU THR LEU ASP GLU LEU GLU LYS LEU PRO VAL ASN          
SEQRES  12 B  167  GLU LYS THR TYR ARG PRO LEU ASN ASP VAL HIS ILE LYS          
SEQRES  13 B  167  ASP ILE THR ILE HIS ALA ASN PRO PHE ALA GLN                  
SEQRES   1 C   11  DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA                  
SEQRES   1 D   11  DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA                  
HET    DAL  C   1       5                                                       
HET    MLE  C   2       9                                                       
HET    MLE  C   3       9                                                       
HET    MVA  C   4       8                                                       
HET    BMT  C   5      13                                                       
HET    ABA  C   6       6                                                       
HET    SAR  C   7       5                                                       
HET    MLE  C   8       9                                                       
HET    MLE  C  10       9                                                       
HET    DAL  D   1       5                                                       
HET    MLE  D   2       9                                                       
HET    MLE  D   3       9                                                       
HET    MVA  D   4       8                                                       
HET    BMT  D   5      13                                                       
HET    ABA  D   6       6                                                       
HET    SAR  D   7       5                                                       
HET    MLE  D   8       9                                                       
HET    MLE  D  10       9                                                       
HETNAM     DAL D-ALANINE                                                        
HETNAM     MLE N-METHYLLEUCINE                                                  
HETNAM     MVA N-METHYLVALINE                                                   
HETNAM     BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE                  
HETNAM     ABA ALPHA-AMINOBUTYRIC ACID                                          
HETNAM     SAR SARCOSINE                                                        
FORMUL   3  DAL    2(C3 H7 N O2)                                                
FORMUL   3  MLE    8(C7 H15 N O2)                                               
FORMUL   3  MVA    2(C6 H13 N O2)                                               
FORMUL   3  BMT    2(C10 H19 N O3)                                              
FORMUL   3  ABA    2(C4 H9 N O2)                                                
FORMUL   3  SAR    2(C3 H7 N O2)                                                
FORMUL   5  HOH   *32(H2 O)                                                     
HELIX    1   1 THR A   27  SER A   40  1                                  14    
HELIX    2   2 GLN A  114  ASP A  118  5                                   5    
HELIX    3   3 GLY A  130  LYS A  139  1                                  10    
HELIX    4   4 THR B   27  SER B   40  1                                  14    
HELIX    5   5 GLN B  114  ASP B  118  5                                   5    
HELIX    6   6 GLY B  130  LYS B  139  1                                  10    
SHEET    1  AA 8 ARG A  50  ILE A  52  0                                        
SHEET    2  AA 8 MET A  56  THR A  59 -1  O  MET A  56   N  ILE A  52           
SHEET    3  AA 8 PHE A 107  THR A 110 -1  O  PHE A 107   N  THR A  59           
SHEET    4  AA 8 VAL A  92  MET A  95 -1  O  VAL A  92   N  THR A 110           
SHEET    5  AA 8 VAL A 123  ASP A 129 -1  N  PHE A 124   O  VAL A  93           
SHEET    6  AA 8 GLY A  16  VAL A  22 -1  O  LYS A  19   N  ILE A 128           
SHEET    7  AA 8 SER A   8  THR A  13 -1  O  VAL A   9   N  ILE A  20           
SHEET    8  AA 8 ILE A 155  HIS A 161 -1  N  LYS A 156   O  HIS A  12           
SHEET    1  BA 9 CYS B  46  ILE B  47  0                                        
SHEET    2  BA 9 HIS B 154  HIS B 161 -1  N  ILE B 155   O  CYS B  46           
SHEET    3  BA 9 SER B   8  THR B  13 -1  O  SER B   8   N  HIS B 161           
SHEET    4  BA 9 GLY B  16  VAL B  22 -1  O  GLY B  16   N  THR B  13           
SHEET    5  BA 9 VAL B 123  ASP B 129 -1  O  LYS B 126   N  GLU B  21           
SHEET    6  BA 9 VAL B  92  MET B  95 -1  O  VAL B  93   N  PHE B 124           
SHEET    7  BA 9 PHE B 107  THR B 110 -1  O  PHE B 108   N  SER B  94           
SHEET    8  BA 9 MET B  56  THR B  59 -1  O  VAL B  57   N  ILE B 109           
SHEET    9  BA 9 ARG B  50  ILE B  52 -1  O  ARG B  50   N  GLN B  58           
SSBOND   1 CYS A   24    CYS A   31                          1555   1555  2.02  
SSBOND   2 CYS B   24    CYS B   31                          1555   1555  2.02  
LINK         C   DAL C   1                 N   MLE C   2     1555   1555  1.34  
LINK         N   DAL C   1                 C   ALA C  11     1555   1555  1.33  
LINK         C   MLE C   2                 N   MLE C   3     1555   1555  1.34  
LINK         C   MLE C   3                 N   MVA C   4     1555   1555  1.34  
LINK         C   MVA C   4                 N   BMT C   5     1555   1555  1.34  
LINK         C   BMT C   5                 N   ABA C   6     1555   1555  1.33  
LINK         C   ABA C   6                 N   SAR C   7     1555   1555  1.35  
LINK         C   SAR C   7                 N   MLE C   8     1555   1555  1.35  
LINK         C   MLE C   8                 N   VAL C   9     1555   1555  1.33  
LINK         C   VAL C   9                 N   MLE C  10     1555   1555  1.34  
LINK         C   MLE C  10                 N   ALA C  11     1555   1555  1.33  
LINK         C   DAL D   1                 N   MLE D   2     1555   1555  1.35  
LINK         N   DAL D   1                 C   ALA D  11     1555   1555  1.33  
LINK         C   MLE D   2                 N   MLE D   3     1555   1555  1.34  
LINK         C   MLE D   3                 N   MVA D   4     1555   1555  1.34  
LINK         C   MVA D   4                 N   BMT D   5     1555   1555  1.35  
LINK         C   BMT D   5                 N   ABA D   6     1555   1555  1.33  
LINK         C   ABA D   6                 N   SAR D   7     1555   1555  1.34  
LINK         C   SAR D   7                 N   MLE D   8     1555   1555  1.35  
LINK         C   MLE D   8                 N   VAL D   9     1555   1555  1.33  
LINK         C   VAL D   9                 N   MLE D  10     1555   1555  1.35  
LINK         C   MLE D  10                 N   ALA D  11     1555   1555  1.33  
SITE     1 AC1 19 GLU A  32  ALA A  36  ALA A  39  ARG A  50                    
SITE     2 AC1 19 PHE A  55  GLN A  58  GLY A  66  ALA A  96                    
SITE     3 AC1 19 ASN A  97  ASN A  98  GLN A 106  PHE A 108                    
SITE     4 AC1 19 HIS A 116  TYR A 121  PRO A 164  HOH A2003                    
SITE     5 AC1 19 SER B   1  VAL B   3  HOH C2001                               
SITE     1 AC2 17 LEU B  35  ALA B  36  ALA B  39  SER B  40                    
SITE     2 AC2 17 ARG B  50  PHE B  55  GLN B  58  GLY B  66                    
SITE     3 AC2 17 ARG B  67  ALA B  96  ASN B  97  ASN B  98                    
SITE     4 AC2 17 GLN B 106  PHE B 108  HIS B 116  TYR B 121                    
SITE     5 AC2 17 HOH B2004                                                     
CRYST1   64.387   64.387  200.943  90.00  90.00 120.00 P 31 2 1     12          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.015531  0.008967  0.000000        0.00000                         
SCALE2      0.000000  0.017934  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.004977        0.00000